The symptom of coronavirus that predicts how bad your case will be
Covid-19 patients have a range of symptoms, but you can tell you how serious your case will be.
Covid-19 has made a way around the world in recent months, with more than three millionPeople infected with coronavirus So far, according to the World Health Organization (WHO). However, all cases of COVID-19 do not look like the same thing. Some people reportNo symptoms, still positive test, while others suffer relatively light symptoms. Some cases are so serious, they are fatal. From the publication, which reports nearly 300,000 CIVID-19 dead on a global scale. All this uncertainty can be troubled. So, if you start suspecting that you are infected, is there a way to know how much your CIVID-19 symptoms can become serious?
According to recent research, possibly yes. An investigation into Cvid-19 patients in KantonSsspital Aarau in Aarau, Switzerland who was published in theOtolaryngology-Head and neck surgery Journal On May 5 shows a correlation between the severity of a patient's loss of smell to the severity of their other CVIV-19 symptoms. (These other symptoms may include shortness of breath, fever and cough.)
The main investigator of the studyAhmad sedaghat, MD, Associate Professor and Researcher for the College of Medicine at the University of Cincinnati, said in a statement that 61% of CIVID-19 patients studied "said"Feeling of odorate reduced or lost. "By comparing that to their other symptoms reported, the researchers were able to draw possible conclusions.
"If anosmia, also known as odor loss, is worse, patients reported that the lack of shortness of breath and a longer fever", also said Seaghat.
Odor loss can also help physicians determine how long a patient has been infected with the virus, which is useful information to determine treatment.
"If anyone has a decrease in the sense of smell with COVID-19, we know they are in the first week of the course of the disease and there is another week or two to two hope," a Added Sedaghat.
By the researcher, early detection can improve the probability that the experimentalAntiviral drug codesivir, which was originally developed by Gilead Sciences to treat Ebola, would be an effective treatment for any particular COVID-19 case. According toKatherine Seley-Radtke, professor of chemistry and biochemistry atUniversity of Maryland, Baltimore County, Remdesvir works in "blocking the RNA of the coronavirus of the coronavirus polymerase", which is one of the key enzymes it must "reproduce its genetic material" and multiply in our bodies.
"Antiviral drugs have always worked better at the beginning of viral infection. The same is hypothesis to be true for remesivir," Sedaghat explained in the statement. "Once remodeivir becomes more widely available, the decrease in the sense of smell can therefore identify patients who would be excellent medicine candidates."
All this is promising, but Sedaghat noted that odor loss is not only one norSymptom of definitive coronavirus. Some patients do not undergo odor loss. Anyway, smell loss alone is not harmful.
"When you start with serious symptoms of Covid-19, which include breathlessness and respiratory distress, it is when you should become alarmed," he said. And whether you are more likely to Covid-19 than others, checkThe type of blood that makes you more at risk of coronavirus.